Detalles de la búsqueda
1.
High-throughput screening of SARS-CoV-2 main and papain-like protease inhibitors
Protein & Cell
; (12): 17-27, 2023.
Artículo
en Inglés
| WPRIM | ID: wpr-971604
2.
Drug target inference by mining transcriptional data using a novel graph convolutional network framework
Protein & Cell
; (12): 281-301, 2022.
Artículo
en Inglés
| WPRIM | ID: wpr-929175
3.
Design, synthesis and biological evaluation of pyrazolo3,4-
Acta Pharmaceutica Sinica B
; (6): 781-794, 2021.
Artículo
en Inglés
| WPRIM | ID: wpr-881169
4.
Discovery of a subtype-selective, covalent inhibitor against palmitoylation pocket of TEAD3
Acta Pharmaceutica Sinica B
; (6): 3206-3219, 2021.
Artículo
en Inglés
| WPRIM | ID: wpr-922788
5.
Effects of Shuanghuanglian oral liquids on patients with COVID-19: a randomized, open-label, parallel-controlled, multicenter clinical trial / 医学前沿
Frontiers of Medicine
; (4): 704-717, 2021.
Artículo
en Inglés
| WPRIM | ID: wpr-922499
6.
Design, synthesis, and biological evaluation of novel tetrahydroprotoberberine derivatives (THPBs) as proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators for the treatment of hyperlipidemia
Acta Pharmaceutica Sinica B
; (6): 1216-1230, 2019.
Artículo
en Inglés
| WPRIM | ID: wpr-815857
7.
Discovery of ARF1-targeting inhibitor demethylzeylasteral as a potential agent against breast cancer
Acta Pharmaceutica Sinica B
; (6): 2619-2622, 2022.
Artículo
en Inglés
| WPRIM | ID: wpr-929387
8.
Structural optimization and biological evaluation of 1,5-disubstituted pyrazole-3-carboxamines as potent inhibitors of human 5-lipoxygenase
Acta Pharmaceutica Sinica B
; (6): 32-45, 2016.
Artículo
en Inglés
| WPRIM | ID: wpr-309987
9.
Application of phosphates and phosphonates prodrugs in drug research and development / 药学学报
Acta Pharmaceutica Sinica
; (12): 621-34, 2013.
Artículo
en Zh
| WPRIM | ID: wpr-445628
10.
Improved synthesis of raltegravir / 中国药科大学学报
Journal of China Pharmaceutical University
; (6): 297-301, 2009.
Artículo
en Zh
| WPRIM | ID: wpr-480387
11.
Structural basis for repurposing a 100-years-old drug suramin for treating COVID-19
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-328336
12.
Discovery of baicalin and baicalein as novel, natural product inhibitors of SARS-CoV-2 3CL protease in vitro
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-038687
13.
Structural basis for repurpose and design of nucleoside drugs for treating COVID-19
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-363812
14.
SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damage and constitutes an antiviral target
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-174953
15.
Structure Basis for Inhibition of SARS-CoV-2 by the Feline Drug GC376
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-138677
16.
Structural Basis for the Inhibition of the RNA-Dependent RNA Polymerase from SARS-CoV-2 by Remdesivir
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-032763
17.
Structure-Based Design, Synthesis and Biological Evaluation of Peptidomimetic Aldehydes as a Novel Series of Antiviral Drug Candidates Targeting the SARS-CoV-2 Main Protease
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-996348
18.
Structure-based drug design, virtual screening and high-throughput screening rapidly identify antiviral leads targeting COVID-19
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-964882
19.
Structures of the Omicron Spike trimer with ACE2 and an anti-Omicron antibody
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-474273
Resultados
1 -
19
de 19
1
Próxima >
>>